Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Agios Pharmaceuticals, Inc.

AGIO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
AGIO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
AGIO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AGIO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in AGIO holdings by institutional investors

Quarterly net insider trading by AGIO's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $30,000 Jul 20, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $70,000 Apr 17, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $20,000 Jan 20, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $10,000 Oct 17, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $20,000 Jul 22, 2025 Issue: Health Issues Medicare/Medicaid Pharmacy
  • $40,000 Oct 16, 2023 Issue: None
  • $40,000 Jul 14, 2023 Issue: None
  • $40,000 Jan 14, 2023 Issue: None
  • $40,000 Oct 16, 2022 Issue: None
  • $40,000 Jul 15, 2022 Issue: None
  • $40,000 Apr 15, 2022 Issue: None
  • $40,000 Jan 15, 2022 Issue: Health Issues
  • $40,000 Oct 15, 2021 Issue: Health Issues
  • $40,000 Jul 17, 2021 Issue: None
  • $30,000 Apr 17, 2021 Issue: None
  • $20,000 Jan 11, 2012 Issue: Budget/Appropriations Defense Health Issues
  • $20,000 Oct 14, 2011 Issue: Defense Health Issues Budget/Appropriations
  • $20,000 Oct 12, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Defense
  • $30,000 Jul 16, 2010 Issue: Defense Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Apr 18, 2010 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Defense
  • $30,000 Jan 06, 2010 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Oct 13, 2009 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Jul 19, 2009 Issue: Medical/Disease Research/Clinical Labs

Former government officials who have lobbied for AGIO

8 former government officials from 6 congressional offices at 2 lobbying firms have lobbied for AGIO, most recently Jul 20, 2026.

  • Lamar Alexander
    John Herzog Senate Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Marsha Blackburn
    Keith Studdard House Legislative Director, Rep. Marsha Blackburn Formerly with Marsha Blackburn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • John Cornyn
    Laura Kemper Senate Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services Formerly with John Cornyn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Mike Kelly
    John Ray House Legislative Assistant, Rep. Mike Kelly Formerly with Mike Kelly · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Lamar Alexander
    Brett Meeks Senate Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Cathy McMorris Rodgers
    Kristin Fritsch House New Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce Formerly with Cathy McMorris Rodgers · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Jul 20, 2026
  • Thomas R. Carper
    Jonathon Jones Senate New Chief of Staff, Senator Carper; Legislative Director, Senator Carper. Formerly with Thomas R. Carper · TIBER CREEK GROUP · Feb 22, 2021
  • Andrew Mckechnie Congress New Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Senator Norm Coleman; Legislative Assistant, Rep. Jim Ramstad; Bipartisan Medical Technology Caucus. Formerly Finance Committee · TIBER CREEK GROUP · Feb 22, 2021

AGIO Estimated quarterly lobbying spending

AGIO Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
AGIO Income Statement
AGIO Balance Sheet
AGIO Cash Flow
U.S. Patents

New AGIO patent grants

  • Patent Title: Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations Jul. 07, 2026
  • Patent Title: Methods of treatment with aminolevulinic acid synthase 2 (alas2) modulators Jun. 30, 2026
  • Patent Title: Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide Apr. 28, 2026
  • Patent Title: Therapeutic compounds and compositions Sep. 30, 2025
  • Patent Title: Pyruvate kinase activators for use in therapy Aug. 05, 2025
  • Patent Title: Pyruvate kinase activators for use in treating blood disorders Nov. 05, 2024
  • Patent Title: Pyruvate kinase activators for use in treating blood disorders Apr. 16, 2024
  • Patent Title: Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations Mar. 05, 2024
  • Patent Title: Mitapivat therapy and modulators of cytochrome p450 Jan. 23, 2024
  • Patent Title: Pyruvate kinase modulators and use thereof Jan. 16, 2024
  • Patent Title: Therapeutic compounds and compositions Jul. 18, 2023
  • Patent Title: Method for treating cell proliferation related disorders May. 29, 2018
  • Patent Title: Pyruvate kinase activators for use in therapy May. 29, 2018
  • Patent Title: Pharmaceutical compositions of therapeutically active compounds May. 15, 2018
  • Patent Title: Therapeutic compositions and related methods of use Apr. 10, 2018
  • Patent Title: Therapeutically active compounds and their methods of use Feb. 13, 2018
  • Patent Title: Therapeutically active compositions and their methods of use Jan. 02, 2018
  • Patent Title: Therapeutically active compositions and their methods of use Dec. 26, 2017
  • Patent Title: Therapeutically active compounds and their methods of use Sep. 05, 2017
  • Patent Title: Therapeutically active compounds and their methods of use Aug. 22, 2017
  • Patent Title: Therapeutically active compounds and their methods of use Aug. 15, 2017
  • Patent Title: N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer Aug. 08, 2017
  • Patent Title: Therapeutically active compounds and their methods of use Jul. 04, 2017
  • Patent Title: Pyruvate kinase activators for use in therapy Jun. 20, 2017
  • Patent Title: Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of idh1 mutants and their use in treating cancer May. 30, 2017
  • Patent Title: Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use May. 23, 2017
  • Patent Title: Therapeutically active compounds and their methods of use May. 23, 2017
  • Patent Title: Methods of evaluating patients using e-cadherin and vimentin Apr. 11, 2017
  • Patent Title: Therapeutically active compounds and their methods of use Feb. 28, 2017
  • Patent Title: Therapeutically active compositions and their methods of use Dec. 06, 2016
  • Patent Title: Therapeutically active compositions and their methods of use Oct. 25, 2016
  • Patent Title: Therapeutic compounds and compositions and their use as pkm2 modulators Oct. 04, 2016
  • Patent Title: Pyruvate kinase activators for use in therapy Aug. 02, 2016
  • Patent Title: Methods of using pyruvate kinase activators Aug. 02, 2016
  • Patent Title: Methods of using pyruvate kinase activators Jul. 12, 2016
  • Patent Title: Therapeutic compounds and compositions Jun. 14, 2016
  • Patent Title: Bicyclic pkm2 activators May. 03, 2016
  • Patent Title: Compounds and their methods of use Apr. 05, 2016
  • Patent Title: N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators Dec. 29, 2015
  • Patent Title: Therapeutic compounds and compositions Dec. 01, 2015
  • Patent Title: Pyruvate kinase activators for use in therapy Nov. 24, 2015
  • Patent Title: Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia Nov. 10, 2015
  • Patent Title: Therapeutic compositions and related methods of use Aug. 25, 2015
  • Patent Title: Therapeutic compounds and compositions Aug. 18, 2015
  • Patent Title: Compounds and their methods of use May. 12, 2015
  • Patent Title: Therapeutic compounds and compositions Nov. 18, 2014
  • Patent Title: Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1 Nov. 11, 2014
  • Patent Title: Therapeutic compounds and compositions Jul. 22, 2014
  • Patent Title: Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use Jun. 03, 2014
  • Patent Title: Pkm2 modulators for use in the treatment of cancer Aug. 06, 2013
Government Contracts

Estimated quarterly amount awarded to AGIO from public contracts

AGIO News

Recent insights relating to AGIO

CNBC Recommendations

Recent picks made for AGIO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AGIO

AGIO Analyst Ratings

AGIO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AGIO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AGIO stock a Buy, Sell, or Hold?

  • What is the price target for $AGIO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AGIO Top Shareholders
Shareholder
Shares Held
AGIO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AGIO stock?

  • Who owns the most shares of $AGIO stock?

  • What funds own $AGIO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AGIO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AGIO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About AGIO

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

  • Address Cambridge, MA
  • Market Cap 2.0 billion
  • Employees 540
  • Industrial Classification Pharmaceutical Preparations

Agios Pharmaceuticals, Inc. (AGIO) Historical Stock Prices

Agios Pharmaceuticals, Inc. (AGIO) closed at $32.90 on September 24, 2026. Over the past year its adjusted close ranged from $22.34 to $45.49. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-2.95%
  • 3 months-9.12%
  • Year to date+20.87%
  • 1 year-11.84%
  • 3 years+34.78%
  • 5 years-30.77%
  • Max+36.97%
See every congressional and insider trade on the AGIO price chart

Quiver Premium charts AGIO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 34.02 34.12 31.37 32.90 32.90 1,635,129
Sep 23, 2026 34.85 35.09 34.09 34.19 34.19 752,478
Sep 22, 2026 34.19 35.36 33.88 34.97 34.97 1,170,409
Sep 21, 2026 33.70 34.13 33.30 33.95 33.95 884,550
Sep 18, 2026 33.29 33.40 32.77 33.07 33.07 1,566,179
Sep 17, 2026 33.42 34.30 33.19 33.61 33.61 956,676
Sep 16, 2026 32.89 33.75 32.73 32.95 32.95 863,620
Sep 15, 2026 33.23 33.48 32.22 32.81 32.81 1,354,035
Sep 14, 2026 33.83 34.35 32.88 33.22 33.22 794,484
Sep 11, 2026 33.94 34.28 33.32 33.60 33.60 750,171
Sep 10, 2026 34.26 35.28 33.21 33.64 33.64 720,256
Sep 9, 2026 33.14 35.38 33.14 34.63 34.63 1,024,568
Sep 8, 2026 32.53 33.93 32.23 33.55 33.55 816,359
Sep 4, 2026 33.13 33.50 32.92 33.10 33.10 480,161
Sep 3, 2026 34.28 34.39 32.95 33.13 33.13 516,035
Sep 2, 2026 34.49 34.93 33.53 34.13 34.13 771,681
Sep 1, 2026 33.60 34.34 33.21 34.21 34.21 926,955
Aug 31, 2026 33.09 33.87 32.93 33.68 33.68 1,109,643
Aug 28, 2026 33.94 34.36 33.27 33.32 33.32 519,740
Aug 27, 2026 33.94 34.80 33.60 34.28 34.28 1,001,444
Aug 26, 2026 33.84 34.43 33.24 33.99 33.99 812,040
Aug 25, 2026 32.85 34.26 32.84 33.90 33.90 742,188
Aug 24, 2026 33.25 33.25 32.61 32.64 32.64 635,734
Aug 21, 2026 33.62 34.09 32.95 33.09 33.09 577,552
Aug 20, 2026 34.64 35.09 33.61 33.63 33.63 697,493
Aug 19, 2026 35.40 35.98 34.57 35.12 35.12 1,690,406
Aug 18, 2026 33.53 34.83 33.46 34.40 34.40 1,187,837
Aug 17, 2026 33.66 33.98 33.22 33.63 33.63 969,285
Aug 14, 2026 33.10 33.81 32.48 33.56 33.56 1,124,478
Aug 13, 2026 34.35 34.65 33.31 33.47 33.47 939,123
Aug 12, 2026 32.74 34.31 32.33 34.21 34.21 1,223,093
Aug 11, 2026 33.05 33.61 32.22 32.69 32.69 938,748
Aug 10, 2026 31.87 33.10 31.71 32.59 32.59 1,071,534
Aug 7, 2026 32.32 32.61 31.55 32.27 32.27 1,399,666
Aug 6, 2026 31.44 32.57 31.44 31.95 31.95 1,188,198
Aug 5, 2026 31.99 32.30 31.29 31.72 31.72 915,635
Aug 4, 2026 31.04 31.75 30.23 31.60 31.60 1,072,529
Aug 3, 2026 30.78 30.94 29.32 30.54 30.54 1,189,503
Jul 31, 2026 33.34 33.34 29.94 30.02 30.02 2,102,051
Jul 30, 2026 29.48 33.50 29.15 32.75 32.75 3,134,456
Jul 29, 2026 35.83 36.37 34.87 35.01 35.01 1,155,276
Jul 28, 2026 37.49 37.56 35.24 35.99 35.99 834,945
Jul 27, 2026 37.04 38.74 36.23 36.97 36.97 992,589
Jul 24, 2026 36.46 36.67 35.61 36.36 36.36 890,110
Jul 23, 2026 35.13 36.68 35.09 36.28 36.28 778,074
Jul 22, 2026 37.36 37.36 35.80 36.05 36.05 902,997
Jul 21, 2026 35.80 39.37 35.63 37.36 37.36 3,403,677
Jul 20, 2026 39.69 40.50 39.69 40.06 40.06 635,511
Jul 17, 2026 38.02 39.74 38.01 39.61 39.61 773,957
Jul 16, 2026 39.70 39.70 38.26 38.72 38.72 726,959
Jul 15, 2026 39.54 40.15 38.98 39.87 39.87 625,035
Jul 14, 2026 40.48 40.54 39.49 39.92 39.92 672,959
Jul 13, 2026 40.67 41.10 39.43 40.55 40.55 713,939
Jul 10, 2026 42.93 42.93 40.26 41.23 41.23 1,133,854
Jul 9, 2026 42.58 43.17 41.96 42.79 42.79 520,058
Jul 8, 2026 43.47 44.00 42.52 42.76 42.76 1,618,459
Jul 7, 2026 39.38 44.09 39.38 44.01 44.01 2,776,297
Jul 6, 2026 37.17 37.69 36.77 37.39 37.39 476,106
Jul 2, 2026 37.42 37.70 36.52 37.58 37.58 791,174
Jul 1, 2026 37.06 38.38 36.35 37.08 37.08 1,133,166
Jun 30, 2026 38.31 38.31 37.00 37.11 37.11 987,909
Jun 29, 2026 37.58 38.08 37.20 38.04 38.04 771,616
Jun 26, 2026 36.36 38.29 35.90 37.90 37.90 3,836,443
Jun 25, 2026 36.23 37.26 35.79 36.20 36.20 773,322
Jun 24, 2026 35.91 36.90 35.32 36.28 36.28 1,028,004
Jun 23, 2026 34.82 35.80 34.63 35.59 35.59 744,424
Jun 22, 2026 34.30 35.53 34.30 35.10 35.10 1,378,943
Jun 18, 2026 33.90 34.45 33.50 34.16 34.16 2,241,589
Jun 17, 2026 32.00 33.77 31.83 33.08 33.08 920,521
Jun 16, 2026 31.98 32.52 31.30 31.84 31.84 788,087
Jun 15, 2026 29.69 31.83 29.27 31.82 31.82 1,651,789
Jun 12, 2026 28.80 30.23 28.51 29.46 29.46 1,141,117
Jun 11, 2026 28.46 29.10 28.16 28.72 28.72 2,194,783
Jun 10, 2026 28.10 29.04 27.70 28.88 28.88 1,021,760
Jun 9, 2026 27.69 28.45 26.89 28.14 28.14 1,290,568
Jun 8, 2026 28.66 28.74 27.18 27.44 27.44 520,708
Jun 5, 2026 28.95 29.39 28.13 28.29 28.29 561,318
Jun 4, 2026 28.12 29.32 27.93 28.79 28.79 648,160
Jun 3, 2026 26.51 27.75 26.49 27.68 27.68 679,237
Jun 2, 2026 28.20 28.30 26.44 26.51 26.51 1,101,084
Jun 1, 2026 29.10 29.25 27.51 28.00 28.00 853,880
May 29, 2026 29.09 30.28 28.50 29.40 29.40 1,434,544
May 28, 2026 28.62 30.53 28.55 30.42 30.42 987,583
May 27, 2026 28.57 28.98 28.32 28.62 28.62 934,965
May 26, 2026 28.25 28.46 27.51 28.33 28.33 903,180
May 22, 2026 28.69 29.10 28.04 28.14 28.14 874,516
May 21, 2026 28.06 28.80 27.68 28.79 28.79 522,743
May 20, 2026 27.78 28.85 27.64 28.50 28.50 678,361
May 19, 2026 28.46 28.46 27.45 27.73 27.73 638,198
May 18, 2026 28.16 28.67 27.75 28.21 28.21 757,913
May 15, 2026 28.50 28.65 27.88 28.17 28.17 604,084
May 14, 2026 28.90 29.18 28.32 28.73 28.73 681,852
May 13, 2026 28.21 28.87 28.08 28.77 28.77 747,397
May 12, 2026 28.30 28.48 27.55 28.42 28.42 766,918
May 11, 2026 27.79 29.01 27.71 27.99 27.99 794,284
May 8, 2026 27.50 28.21 27.50 27.79 27.79 582,937
May 7, 2026 27.20 27.57 26.94 27.53 27.53 722,509
May 6, 2026 27.40 27.51 26.51 26.98 26.98 1,083,942
May 5, 2026 27.42 28.00 26.93 27.21 27.21 870,475
May 4, 2026 27.92 28.10 27.03 27.56 27.56 1,578,826
May 1, 2026 28.00 28.40 27.25 28.16 28.16 1,166,004
Apr 30, 2026 28.07 28.68 27.71 28.00 28.00 1,306,003
Apr 29, 2026 26.50 28.82 25.65 28.05 28.05 2,814,091
Apr 28, 2026 24.55 25.34 24.48 24.80 24.80 885,503
Apr 27, 2026 25.12 25.84 24.29 24.43 24.43 1,070,641
Apr 24, 2026 25.57 25.59 24.92 25.32 25.32 972,458
Apr 23, 2026 26.75 26.94 25.62 25.74 25.74 1,020,357
Apr 22, 2026 26.49 26.95 26.06 26.72 26.72 1,586,429
Apr 21, 2026 26.84 27.04 26.05 26.29 26.29 1,617,265
Apr 20, 2026 29.58 29.70 26.05 27.07 27.07 5,823,349
Apr 17, 2026 35.50 35.80 34.87 35.14 35.14 673,153
Apr 16, 2026 34.68 35.09 34.34 34.92 34.92 832,208
Apr 15, 2026 33.28 34.48 33.23 34.45 34.45 572,157
Apr 14, 2026 33.14 33.90 32.91 33.30 33.30 652,593
Apr 13, 2026 32.92 33.61 32.83 33.15 33.15 693,829
Apr 10, 2026 32.97 33.17 32.47 32.92 32.92 765,236
Apr 9, 2026 33.53 33.53 32.59 32.92 32.92 867,783
Apr 8, 2026 35.43 35.99 33.68 33.77 33.77 1,236,136
Apr 7, 2026 34.80 35.31 34.48 35.11 35.11 1,483,767
Apr 6, 2026 35.46 35.98 34.55 34.80 34.80 1,068,723
Apr 2, 2026 33.97 35.34 33.52 35.20 35.20 1,425,474
Apr 1, 2026 33.89 36.16 33.87 34.19 34.19 1,557,336
Mar 31, 2026 33.72 36.35 33.67 33.83 33.83 3,606,788
Mar 30, 2026 29.43 30.09 29.03 29.61 29.61 821,103
Mar 27, 2026 29.71 30.00 29.25 29.43 29.43 797,116
Mar 26, 2026 29.16 30.87 29.16 29.95 29.95 1,129,849
Mar 25, 2026 28.78 30.16 28.59 29.59 29.59 726,342
Mar 24, 2026 27.73 28.65 27.40 28.35 28.35 786,622
Mar 23, 2026 28.19 28.70 27.67 28.11 28.11 811,882
Mar 20, 2026 27.89 28.35 27.49 27.86 27.86 1,618,703
Mar 19, 2026 28.29 28.44 27.50 27.92 27.92 605,936
Mar 18, 2026 28.57 28.81 28.00 28.13 28.13 540,728
Mar 17, 2026 28.67 29.45 28.67 28.91 28.91 625,172
Mar 16, 2026 27.71 28.93 27.71 28.84 28.84 559,156
Mar 13, 2026 27.76 28.19 27.26 27.85 27.85 510,316
Mar 12, 2026 27.51 27.80 27.00 27.59 27.59 463,854
Mar 11, 2026 28.17 28.23 27.32 28.07 28.07 432,597
Mar 10, 2026 28.51 28.97 28.00 28.26 28.26 526,639
Mar 9, 2026 27.53 28.62 27.52 28.53 28.53 779,693
Mar 6, 2026 27.27 27.59 26.84 27.47 27.47 855,929
Mar 5, 2026 28.14 28.38 27.47 27.68 27.68 1,020,463
Mar 4, 2026 28.67 29.37 28.13 28.19 28.19 918,660
Mar 3, 2026 28.28 29.30 27.71 28.48 28.48 919,223
Mar 2, 2026 29.80 30.34 28.11 29.20 29.20 1,204,675
Feb 27, 2026 29.33 30.52 29.01 30.23 30.23 764,570
Feb 26, 2026 29.82 30.05 29.05 29.98 29.98 645,541
Feb 25, 2026 30.46 30.86 29.80 29.96 29.96 652,225
Feb 24, 2026 30.35 31.02 29.71 30.39 30.39 1,201,180
Feb 23, 2026 29.29 30.40 29.13 30.20 30.20 1,066,309
Feb 20, 2026 28.46 29.28 28.23 29.25 29.25 979,229
Feb 19, 2026 27.51 28.81 27.50 28.58 28.58 723,236
Feb 18, 2026 27.53 27.89 27.07 27.56 27.56 707,942
Feb 17, 2026 27.80 28.20 27.43 27.82 27.82 674,571
Feb 13, 2026 28.71 28.97 27.76 27.96 27.96 650,636
Feb 12, 2026 27.85 28.93 27.10 28.07 28.07 975,855
Feb 11, 2026 26.60 27.72 26.05 27.71 27.71 976,106
Feb 10, 2026 27.10 27.46 26.84 27.13 27.13 736,295
Feb 9, 2026 26.45 26.98 26.04 26.94 26.94 678,385
Feb 6, 2026 27.03 27.43 26.50 26.53 26.53 1,151,622
Feb 5, 2026 27.48 28.07 26.45 26.57 26.57 1,107,727
Feb 4, 2026 28.19 28.19 27.55 27.70 27.70 959,448
Feb 3, 2026 28.11 28.71 27.59 27.93 27.93 808,307
Feb 2, 2026 27.18 28.71 26.53 28.16 28.16 922,132
Jan 30, 2026 27.46 27.92 26.95 27.44 27.44 553,341
Jan 29, 2026 28.30 28.57 27.41 27.61 27.61 827,515
Jan 28, 2026 28.79 29.04 28.22 28.31 28.31 1,187,357
Jan 27, 2026 28.80 29.93 28.42 28.67 28.67 913,587
Jan 26, 2026 28.50 29.16 28.03 28.83 28.83 1,142,723
Jan 23, 2026 28.57 29.10 27.82 28.54 28.54 993,407
Jan 22, 2026 27.25 28.75 27.13 28.66 28.66 792,012
Jan 21, 2026 26.73 27.32 26.42 27.17 27.17 1,133,145
Jan 20, 2026 26.50 27.07 26.25 26.68 26.68 897,659
Jan 16, 2026 27.87 28.23 27.11 27.19 27.19 975,838
Jan 15, 2026 28.87 28.87 27.75 27.80 27.80 805,474
Jan 14, 2026 27.79 28.79 27.52 28.73 28.73 769,203
Jan 13, 2026 28.00 28.46 27.30 27.80 27.80 658,980
Jan 12, 2026 28.10 28.38 27.34 28.32 28.32 904,468
Jan 9, 2026 28.55 28.70 28.02 28.41 28.41 1,171,343
Jan 8, 2026 28.24 28.64 27.91 28.16 28.16 1,095,509
Jan 7, 2026 27.47 29.44 27.47 28.54 28.54 1,299,570
Jan 6, 2026 27.34 27.67 27.10 27.47 27.47 927,714
Jan 5, 2026 27.17 27.59 26.54 27.45 27.45 1,067,951
Jan 2, 2026 27.25 27.25 26.56 27.18 27.18 947,024
Dec 31, 2025 27.18 27.61 26.74 27.22 27.22 870,797
Dec 30, 2025 27.02 27.41 26.66 27.33 27.33 982,193
Dec 29, 2025 27.92 28.00 27.05 27.16 27.16 1,019,819
Dec 26, 2025 29.06 29.06 27.42 28.02 28.02 1,705,616
Dec 24, 2025 28.00 30.04 27.10 29.17 29.17 6,310,491
Dec 23, 2025 24.95 24.95 24.44 24.59 24.59 915,709
Dec 22, 2025 24.53 25.06 24.16 24.95 24.95 2,564,378
Dec 19, 2025 25.07 25.30 24.25 24.46 24.46 3,773,021
Dec 18, 2025 25.78 26.22 24.60 24.73 24.73 1,174,521
Dec 17, 2025 26.19 26.36 25.41 25.45 25.45 1,417,537
Dec 16, 2025 26.72 26.90 25.98 26.09 26.09 1,039,028
Dec 15, 2025 27.60 27.95 26.52 26.85 26.85 1,182,812
Dec 12, 2025 27.52 27.66 26.78 27.27 27.27 1,203,135
Dec 11, 2025 27.84 28.25 27.26 27.46 27.46 1,511,508
Dec 10, 2025 27.03 28.61 26.86 28.00 28.00 1,630,066
Dec 9, 2025 27.42 27.64 26.80 26.85 26.85 1,002,985
Dec 8, 2025 27.60 28.57 27.12 27.28 27.28 1,091,834
Dec 5, 2025 27.56 27.95 27.05 27.73 27.73 850,263
Dec 4, 2025 27.35 27.68 27.13 27.42 27.42 1,225,717
Dec 3, 2025 27.15 27.73 26.99 27.49 27.49 1,201,115
Dec 2, 2025 27.74 27.99 26.81 26.98 26.98 1,727,133
Dec 1, 2025 28.51 28.55 27.63 27.84 27.84 1,501,323
Nov 28, 2025 29.30 29.30 28.45 29.20 29.20 500,589
Nov 26, 2025 28.85 29.46 27.84 29.04 29.04 1,857,218
Nov 25, 2025 27.19 28.63 26.36 28.43 28.43 2,298,052
Nov 24, 2025 25.56 26.75 24.96 26.49 26.49 4,268,829
Nov 21, 2025 24.66 25.94 23.00 25.24 25.24 3,636,028
Nov 20, 2025 23.30 25.98 23.05 24.57 24.57 7,666,286
Nov 19, 2025 23.29 25.07 22.24 22.34 22.34 17,657,857
Nov 18, 2025 44.92 46.00 44.40 45.49 45.49 568,958
Nov 17, 2025 43.59 45.96 42.50 45.13 45.13 882,906
Nov 14, 2025 41.89 44.29 41.34 43.65 43.65 848,753
Nov 13, 2025 43.12 44.22 42.47 42.54 42.54 666,849
Nov 12, 2025 43.84 44.55 43.20 43.63 43.63 876,811
Nov 11, 2025 41.24 43.90 41.16 43.86 43.86 530,990
Nov 10, 2025 41.02 42.07 41.00 41.38 41.38 465,407
Nov 7, 2025 40.19 41.48 39.38 40.67 40.67 378,760
Nov 6, 2025 40.26 40.86 39.94 40.31 40.31 380,689
Nov 5, 2025 40.25 40.72 39.21 40.51 40.51 503,629
Nov 4, 2025 39.33 40.32 38.90 40.00 40.00 711,169
Nov 3, 2025 42.86 44.10 39.96 40.13 40.13 834,707
Oct 31, 2025 42.86 43.72 42.26 43.24 43.24 735,186
Oct 30, 2025 42.18 43.81 40.18 43.18 43.18 989,605
Oct 29, 2025 42.96 43.47 41.82 41.96 41.96 564,849
Oct 28, 2025 42.97 43.78 42.45 43.43 43.43 647,360
Oct 27, 2025 43.39 44.25 43.01 43.08 43.08 546,182
Oct 24, 2025 42.61 43.43 42.10 43.33 43.33 343,056
Oct 23, 2025 41.92 42.11 41.27 42.09 42.09 324,809
Oct 22, 2025 43.12 43.54 41.24 41.74 41.74 367,616
Oct 21, 2025 42.82 43.67 42.31 43.45 43.45 481,559
Oct 20, 2025 43.05 43.24 42.00 42.65 42.65 508,964
Oct 17, 2025 41.85 43.69 41.85 42.33 42.33 756,204
Oct 16, 2025 41.40 42.47 41.01 41.52 41.52 927,863
Oct 15, 2025 40.31 41.71 40.14 41.38 41.38 515,233
Oct 14, 2025 40.21 41.09 39.71 40.24 40.24 387,552
Oct 13, 2025 40.61 41.73 40.35 40.92 40.92 540,530
Oct 10, 2025 42.51 42.51 40.20 40.61 40.61 657,682
Oct 9, 2025 42.65 43.21 41.92 42.43 42.43 539,986
Oct 8, 2025 41.00 42.61 40.84 42.60 42.60 519,164
Oct 7, 2025 40.94 41.29 40.39 40.87 40.87 319,809
Oct 6, 2025 40.62 41.06 40.36 40.89 40.89 446,712
Oct 3, 2025 40.06 41.42 39.79 40.50 40.50 525,442
Oct 2, 2025 40.36 40.58 39.32 39.93 39.93 392,505
Oct 1, 2025 40.09 41.24 39.67 40.07 40.07 677,710
Sep 30, 2025 39.44 40.20 38.76 40.14 40.14 574,841
Sep 29, 2025 38.73 39.64 38.08 39.27 39.27 573,363
Sep 26, 2025 37.02 39.26 36.39 38.93 38.93 814,462
Sep 25, 2025 37.23 37.23 36.43 36.61 36.61 474,554
Sep 24, 2025 37.83 38.09 37.03 37.32 37.32 495,638

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Agios Pharmaceuticals, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at AGIO, per a recent SEC DEF 14A filing. We estimate that the median employee at AGIOS PHARMACEUTICALS, INC. is paid $331,591.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation